Advertisement

Topics

AbbVie inks deal with Teneobio to develop BCMA-targeting bispecific antibody for multiple myeloma https://www.firstwordpharma.com/node/1624570  $ABBV

08:48 EST 11 Feb 2019 | FirstWord Pharma

AbbVie inks deal with Teneobio to develop BCMA-targeting bispecific antibody for multiple myeloma https://www.firstwordpharma.com/node/1624570 

Original Article: AbbVie inks deal with Teneobio to develop BCMA-targeting bispecific antibody for multiple myeloma https://www.firstwordpharma.com/node/1624570  $ABBV

NEXT ARTICLE

More From BioPortfolio on "AbbVie inks deal with Teneobio to develop BCMA-targeting bispecific antibody for multiple myeloma https://www.firstwordpharma.com/node/1624570  $ABBV"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...